Live
  • Stocks
  • ETFs
  • Commodities
    AstraZeneca's $50B U.S. Bet Amid Pharma Tariff Tensions

    AstraZeneca's $50B U.S. Bet Amid Pharma Tariff Tensions

    AstraZeneca announces a landmark $50 billion investment in the U.S., centering on a new state-of-t...

    Read More
    Rolls-Royce's $75M Bet on South Carolina: What It Means

    Rolls-Royce's $75M Bet on South Carolina: What It Means

    Rolls-Royce's $75 million expansion in South Carolina signals a strategic commitment to U.S. manuf...

    Read More